Jason Gardner
CEO
Chairman
Board Member
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Marqeta, Inc. (MQ) | Executive Chairman | $349,872 | $600,764 |
| 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. Former President and Chief Executive Officer | $57,861 | $667,649 |
| 2022 | Marqeta, Inc. (MQ) | Executive Chairman | $580,000 | $1,180,634 |
| 2022 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. Former President and Chief Executive Officer | $565,000 | $1,654,848 |
| 2021 | Marqeta, Inc. (MQ) | Executive Chairman | $350,000 | $224,387,431 |
| 2021 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. President and Chief Executive Officer | $545,000 | $2,228,102 |
| 2020 | Marqeta, Inc. (MQ) | Executive Chairman, Former Chief Executive Officer | $350,000 | $1,692,518 |
| 2020 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. President and Chief Executive Officer | $530,000 | $3,102,848 |
| 2019 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. President and Chief Executive Officer | $515,000 | $1,651,001 |
| 2018 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | D.Phil. President and Chief Executive Officer | $460,000 | $4,749,458 |
Executive changes
Earnings-call appearances
-
Marqeta, Inc. Q3 FY2022 Earnings Call2022-11-09
Marqeta, Inc. (MQ)
-
Marqeta, Inc. Q2 FY2022 Earnings Call2022-08-10
Marqeta, Inc. (MQ)
-
Marqeta, Inc. Q1 FY2022 Earnings Call2022-05-11
Marqeta, Inc. (MQ)
-
Marqeta, Inc. Q4 FY2021 Earnings Call2022-03-09
Marqeta, Inc. (MQ)
-
Marqeta, Inc. Q3 FY2021 Earnings Call2021-11-10
Marqeta, Inc. (MQ)
-
Marqeta, Inc. Q2 FY2021 Earnings Call2021-08-11
Marqeta, Inc. (MQ)